Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus
Cancer Science · 2024
DOI: 10.1111/cas.16105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Danya Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou Univers…. Hauptthemen laut MEDLINE: Oncolytic Viruses, Oncolytic Virotherapy, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Oncolytic viruses (OVs) possess the unique ability to selectively replicate within tumor cells, leading to their destruction, while also reversing the immunosuppression within the tumor microenvironment and triggering an antitumor immune response. As a result, OVs have emerged as one of the most promising approaches in cancer therapy. However, the effective delivery of intravenously administered OVs faces significant challenges imposed by various immune cells within the peripheral blood, hindering their access to tumor sites. Notably, neutrophils, the predominant white blood cell population comprising approximately 50%–70% of circulating white cells in humans, show phagocytic properties. Our investigation revealed that the majority of oncolytic vaccinia viruses (VV) are engulfed and degraded by neutrophils in the bloodstream. The depletion of neutrophils using the anti‐LY6G Ab (1‐A8) resulted in an increased accumulation of circulating oncolytic VV in the peripheral blood and enhanced deposition at the tumor site, consequently amplifying the antitumor effect. Neutrophils heavily rely on PI3K signaling to sustain their phagocytic process. Additionally, our study determined that the inhibition of the PI3Kinase delta isoform by idelalisib (CAL‐101) suppressed the uptake of oncolytic VV by neutrophils. This inhibition led to a greater presence of oncolytic VV in both the peripheral blood and at the tumor site, resulting in improved efficacy against the tumor. In conclusion, our study showed that inhibiting neutrophil functions can significantly enhance the antitumor efficacy of intravenous oncolytic VV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Centre for International Research in Cell and Gene Therapy, School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
- Pancreatic Surgery Department, Shanghai Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
- Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- R&D Department, Huayao Kangming Biopharmaceutical Co., Ltd, Shenzhen, China.
ORCID-Profile: Ming Yuan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, D., Xu, W., Ding, X., Guo, H., Wang, J., Zhao, G., Zhang, C., Zhang, Z., Wang, Z., Wang, P., Lu, L., & Yuan, M. (2024). Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus. Cancer Science. https://doi.org/10.1111/cas.16105
Vancouver
Zhou D, Xu W, Ding X, Guo H, Wang J, Zhao G, et al. Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus. Cancer Science. 2024. doi:10.1111/cas.16105
BibTeX
@article{Zhou2024,
author = {Zhou, Danya and Xu, Wei and Ding, Xuping and Guo, Haoran and Wang, Jianyao and Zhao, Guanghao and Zhang, Chenglin and Zhang, Zhongxian and Wang, Zhimin and Wang, Pengju and Lu, Liming and Yuan, Ming},
title = {Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16105}
}
EUVIMED